ergonovine has been researched along with substance p in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kai, H; Kikuchi, Y; Noma, M; Sugihara, M; Suzuki, S; Tajimi, T; Yamamoto, H; Yoshimura, H | 1 |
| Crossman, DC; Davies, GJ; Fuller, RW; Larkin, SW; Maseri, A | 1 |
| Yamamoto, H | 1 |
3 other study(ies) available for ergonovine and substance p
| Article | Year |
|---|---|
Preservation of endothelium-dependent vasodilation in the spastic segment of the human epicardial coronary artery by substance P.
Topics: Angina Pectoris, Variant; Coronary Angiography; Coronary Vasospasm; Coronary Vessels; Endothelium, Vascular; Ergonovine; Female; Humans; Male; Middle Aged; Nitric Oxide; Substance P; Vasodilation | 1992 |
Substance P dilates epicardial coronary arteries and increases coronary blood flow in humans.
Topics: Adult; Aged; Chest Pain; Coronary Angiography; Coronary Circulation; Coronary Vessels; Dose-Response Relationship, Drug; Ergonovine; Female; Hemodynamics; Humans; Iohexol; Male; Middle Aged; Oxygen Consumption; Substance P; Vasoconstriction; Vasodilation | 1989 |
Preserved endothelial function in the spastic segment of the human epicardial coronary artery in patients with variant angina--role of substance P in evaluating endothelial function.
Topics: Acetylcholine; Aged; Angina Pectoris, Variant; Coronary Vasospasm; Coronary Vessels; Dose-Response Relationship, Drug; Endothelium, Vascular; Ergonovine; Humans; Middle Aged; Nitric Oxide; Substance P | 1993 |